View in EDS HTML Full Text PDF Full Text

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.

Saved in:
Bibliographic Details
Title: Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.
Authors: Pianko MJ; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA., Funt SA; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA., Page DB; b Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USA., Cattry D; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA., Scott EC; c Hematology/Oncology Division , Oregon Health and Science University , Portland , OR , USA., Ansell SM; d Division of Hematology, Mayo Clinic Cancer Center , Hematologic Malignancies Program, Center for Immunology and Immune Therapies , Rochester , MN , USA., Borrello IM; e Hematologic Malignancies Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA., Gutierrez M; f John Theurer Cancer Center, Hackensack University Medical Center , Hackensack , NJ , USA., Lendvai N; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA., Hassoun H; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA., Landgren CO; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA., Lesokhin AM; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2018 Jan; Vol. 59 (1), pp. 221-224. Date of Electronic Publication: 2017 May 30.
Publication Type: Clinical Trial, Phase I; Letter; Multicenter Study
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28554253
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pianko+MJ%22">Pianko MJ</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Funt+SA%22">Funt SA</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Page+DB%22">Page DB</searchLink>; b Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USA.<br /><searchLink fieldCode="AU" term="%22Cattry+D%22">Cattry D</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Scott+EC%22">Scott EC</searchLink>; c Hematology/Oncology Division , Oregon Health and Science University , Portland , OR , USA.<br /><searchLink fieldCode="AU" term="%22Ansell+SM%22">Ansell SM</searchLink>; d Division of Hematology, Mayo Clinic Cancer Center , Hematologic Malignancies Program, Center for Immunology and Immune Therapies , Rochester , MN , USA.<br /><searchLink fieldCode="AU" term="%22Borrello+IM%22">Borrello IM</searchLink>; e Hematologic Malignancies Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.<br /><searchLink fieldCode="AU" term="%22Gutierrez+M%22">Gutierrez M</searchLink>; f John Theurer Cancer Center, Hackensack University Medical Center , Hackensack , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Lendvai+N%22">Lendvai N</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Hassoun+H%22">Hassoun H</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Landgren+CO%22">Landgren CO</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Lesokhin+AM%22">Lesokhin AM</searchLink>; a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2018 Jan; Vol. 59 (1), pp. 221-224. <i>Date of Electronic Publication: </i>2017 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Letter; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28554253
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2017.1320713
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 221
    Titles:
      – TitleFull: Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pianko MJ
      – PersonEntity:
          Name:
            NameFull: Funt SA
      – PersonEntity:
          Name:
            NameFull: Page DB
      – PersonEntity:
          Name:
            NameFull: Cattry D
      – PersonEntity:
          Name:
            NameFull: Scott EC
      – PersonEntity:
          Name:
            NameFull: Ansell SM
      – PersonEntity:
          Name:
            NameFull: Borrello IM
      – PersonEntity:
          Name:
            NameFull: Gutierrez M
      – PersonEntity:
          Name:
            NameFull: Lendvai N
      – PersonEntity:
          Name:
            NameFull: Hassoun H
      – PersonEntity:
          Name:
            NameFull: Landgren CO
      – PersonEntity:
          Name:
            NameFull: Lesokhin AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2018 Jan
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 59
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1